Contraception

Contemporary OB/GYN® will continue to update this story as new information becomes available.

A recent study highlights barriers to pregnancy prevention for women without permanent housing.

Despite the popularity of birth control pills and their decades of safe use and research people still face barriers to birth control pills, said senior author Sarah Baum.

A look at contraceptive methods and how they are poised to affect women’s health.

A literature review published in the journal Contraception finds progestin-only pills (POP) may be more effective than expected.

For medication abortion, a single dose of letrozole 30 mg prior to misoprostol 800 mcg buccally is not effective, according to a recently published pilot study.

In this interview, Michael Krychman, MD, a community-based gynecologist in Newport Beach, California, takes a look at 2022 advances within the contraceptive space, as well as looks toward the future.

Community pharmacists need more support and resources to provide quality contraceptive counseling and care, according to a study published in BMJ Sexual and Reproductive Health.

Women on Medicaid with opioid use disorder (OUD) who use medications for opioid use disorder (MOUD) are more likely to use contraception and to undergo female sterilization than peers not prescribed MOUD, according to a study in Contraception.

Fertility myths and declining sexual satisfaction may contribute to shortfalls in contraceptive use after cancer treatment, a new study concludes.

Understanding the effects is imperative for patient satisfaction.

An umbrella review of meta-analysis studies on hormonal contraceptives published in JAMA Network Open finds no high-quality evidence that they cause major adverse health outcomes such as stroke or cancer.

Jenna Beckham, MD, MSPH, FACOG, and Thomas Kimble, MD, comment on unmet needs and challenges faced by patients looking for contraception.

Experts in gynecology share practical resources for patients and providers on the currently available contraceptive options.

Drs Jenna Beckham and Thomas Kimble review the benefits of newly approved contraceptive systems, such as use in women with higher BMIs and ease of access.

The contraception and abortion care workforce in the United States significantly decreased during the first year of the COVID-19 pandemic, according to a research letter published in JAMA Network Open.

Jenna Beckham, MD, MSPH, FACOG, and Thomas Kimble, MD, discuss patient misconceptions around contraceptive options and the impact on adherence.

Drs Jenna Beckham and Thomas Kimble comment on hormonal patch and vaginal gel contraceptives.

Experts in gynecology review other contraception methods, including the contraceptive ring and drospirenone and estetrol tablets.

The US Food and Drug Administration recently updated its guidelines for dispensing mifepristone (the “abortion pill”) to now include certified pharmacies.

Jenna Beckham, MD, MSPH, FACOG, and Thomas Kimble, MD, provide an overview of newly approved contraceptive modalities.

Thomas Kimble, MD, reviews potential cardiovascular risks associated with some contraceptives.

A substudy of the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial, which compared three highly effective, reversible methods of contraception, concluded that women assigned either a copper intrauterine device (Cu-IUD) or the levonorgestrel (LNG) implant may have had condomless sex more frequently than women assigned to intramuscular depo-medroxyprogesterone acetate (DMPA-IM).

Drs Jenna Beckham and Thomas Kimble discuss the safety and efficacy of contraceptives for patients with a higher body mass Index (BMI).

Thomas Kimble, MD, provides an overview of currently available hormonal contraceptive options.